Mok Anna Hoi Ying – HKU COVID-19 Digital Archives

Mok Anna Hoi Ying

DEPT

Department of Family Medicine and Primary Care

FACULTY

Li Ka Shing Faculty of Medicine

COVID-19 Contribution

Showing 1 - 7 out of 7

Show

Relevance

01 Apr 2023
Effectiveness of Molnupiravir and Nirmatrelvir–Ritonavir in Hospitalized Patients With COVID-19
Background: Whether hospitalized patients benefit from COVID-19 oral antivirals is uncertain. Objective: To examine the real-world effectiveness of mo...Read more
W
Wan, YFE
Y
Yan, KCV
M
Mok, AHY
W
Wang, B
X
Xu, W
C
Cheng, FWT
L
Lai, TTF
L
Li, X
W
Wong, CKH
L
Li, PH
C
Cowling, BJ
H
Hung, FNI
L
Lau, WCS
W
Wong, ICK
C
Chan, EWY
31 Dec 2022
Effectiveness of BNT162b2 and CoronaVac vaccinations against mortality and severe complications after SARS-CoV-2 Omicron BA.2 infection: a case–control study
Data regarding protection against mortality and severe complications after Omicron BA.2 infection with CoronaVac and BNT162b2 vaccines remains limited...Read more
Y
Yan, KCV
W
Wan, YFE
Y
Ye, X
M
Mok, AHY
L
Lai, TTF
C
Chui, SLC
L
Li, X
W
Wong, CKH
L
Li, PH
M
Ma, T
Q
Qin, S
C
Cowling, BJ
L
Leung, GM
L
Lau, WCS
W
Wong, ICK
C
Chan, EWY
03 May 2023
Waning effectiveness against COVID-19-related hospitalization, severe complications, and mortality with two to three doses of CoronaVac and BNT162b2: a case–control study
BACKGROUND: This study aims to evaluate waning effectiveness against severe and fatal COVID-19 with two to three doses of CoronaVac/BNT162b2, where da...Read more
Y
Yan, KCV
W
Wan, YFE
Y
Ye, X
M
Mok, AHY
L
Lai, TTF
C
Chui, SLC
L
Li, X
W
Wong, CKH
L
Li, PH
M
Ma, T
Q
Qin, S
L
Lau, WCS
W
Wong, ICK
C
Chan, EWY
drug development Epidemiology General Medicine immunology Infectious disease Microbiology Parasitology virology
02 Dec 2022
mRNA (BNT162b2) and Inactivated (CoronaVac) COVID-19 Vaccination and Risk of Adverse Events and Acute Diabetic Complications in Patients with Type 2 Diabetes Mellitus: A Population-Based Study
Introduction: In Hong Kong, CoronaVac and BNT162b2 have been approved for emergency use owing to the coronavirus disease 2019 (COVID-19) pandemic. Rea...Read more
W
Wan, YFE
C
Chui, SLC
M
Mok, AHY
X
Xu, W
Y
Yan, KCV
L
Lai, TTF
L
Li, X
W
Wong, CKH
C
Chan, EWY
L
Lui, TWD
T
Tan, KCB
H
Hung, FNI
L
Lam, CLK
L
Leung, GM
W
Wong, ICK
27 Dec 2022
Effectiveness of BNT162b2 and CoronaVac vaccinations against SARS-CoV-2 omicron infection in people aged 60 years or above: a case–control study
BACKGROUND: In view of limited evidence that specifically addresses vaccine effectiveness (VE) in the older population, this study aims to evaluate th...Read more
W
Wan, YFE
M
Mok, AHY
Y
Yan, KCV
C
Chan, CIY
W
Wang, B
L
Lai, TTF
C
Chui, SLC
L
Li, X
W
Wong, CKH
L
Lau, WCS
W
Wong, ICK
C
Chan, EWY
01 Nov 2022
Vaccine effectiveness of BNT162b2 and CoronaVac against SARS-CoV-2 Omicron BA.2 infection, hospitalisation, severe complications, cardiovascular disease and mortality in patients with diabetes mellitus: A case control study
W
Wan, YFE
M
Mok, AHY
Y
Yan, KCV
W
Wang, B
Z
Zhang, Y
H
Hong, N
C
Chui, SLC
L
Li, X
W
Wong, CKH
L
Lai, TTF
T
Tan, KCB
L
Lau, WCS
W
Wong, ICK
C
Chan, EWY
01 Jul 2022
Safety of an inactivated, whole-virion COVID-19 vaccine (CoronaVac) in people aged 60 years or older in Hong Kong: a modified self-controlled case series
Background: Because evidence on the safety of COVID-19 vaccines in older adults is scarce, we aimed to evaluate the incidence and risk of adverse even...Read more
W
Wan, YFE
W
Wang, Y
C
Chui, SLC
M
Mok, AHY
X
Xu, W
Y
Yan, KCV
L
Lai, TTF
L
Li, X
W
Wong, CKH
C
Chan, EWY
L
Lau, GKK
C
Cowling, BJ
H
Hung, FNI
W
Wong, ICK

01 Apr 2023

Effectiveness of Molnupiravir and Nirmatrelvir–Ritonavir in Hospitalized Patients With COVID-19

31 Dec 2022

Effectiveness of BNT162b2 and CoronaVac vaccinations against mortality and severe complications after SARS-CoV-2 Omicron BA.2 infection: a case–control study

03 May 2023

Waning effectiveness against COVID-19-related hospitalization, severe complications, and mortality with two to three doses of CoronaVac and BNT162b2: a case–control study

02 Dec 2022

mRNA (BNT162b2) and Inactivated (CoronaVac) COVID-19 Vaccination and Risk of Adverse Events and Acute Diabetic Complications in Patients with Type 2 Diabetes Mellitus: A Population-Based Study

27 Dec 2022

Effectiveness of BNT162b2 and CoronaVac vaccinations against SARS-CoV-2 omicron infection in people aged 60 years or above: a case–control study

01 Nov 2022

Vaccine effectiveness of BNT162b2 and CoronaVac against SARS-CoV-2 Omicron BA.2 infection, hospitalisation, severe complications, cardiovascular disease and mortality in patients with diabetes mellitus: A case control study

01 Jul 2022

Safety of an inactivated, whole-virion COVID-19 vaccine (CoronaVac) in people aged 60 years or older in Hong Kong: a modified self-controlled case series

Site Map

About

Policy

Copyright © 2023 - University Libraries, The University of Hong Kong